Adherex Expands Patent Protection for Vascular Targeting Agents to Include Anti-Angiogenics; Company Receives US Patent for VE-cadherin Blocking Antibodies.
Linked as:
Extract
Adherex Expands Patent Protection for Vascular Targeting Agents to Include Anti-Angiogenics; Company Receives US Patent for VE-cadherin Blocking Antibodies.
Business Editors/Health/Medical Writers
OTTAWA--(BUSINESS WIRE)--July 15, 2003 Adherex Technologies Inc. (TSX:AHX), an Ottawa-based biopharmaceut...See the full content of this document
Sponsored links
